ATLANTA, April 5, 2019 /PRNewswire-PRWeb/ -- Pharm Origins, a leading US based nutraceutical manufacturer, has announced the official release of Cholafarin, a sublingual cardiac supplement.
The science of Cholafarin is based on ground breaking research that was conducted by Ohio University in late 2017.
Through a series of cutting-edge tests, Ohio University Doctors were able to identify a naturally occurring compound that supported the regeneration of aging and dying cardiac tissue.
This information can be used in a variety of important ways to benefit the human heart including the support of normal blood pressure levels.
"As a leading natural health company we watched the Ohio University studies very closely and the results were simply astounding," said Clint Winters, Pharm Origins spokesperson and natural health expert.
He went on to say, "As soon as the results became clinically proven we moved to release this cardiac breakthrough to the world."
Pharm Origins is known for its ability to extract rare and fragile natural ingredients via their patented ethyl extraction system.
In the development of Cholafarin they used this process to extract a rare and natural hormone that benefits human heart tissue.
The net result was a powerful cardiac supplement with incredible backing and clinical research.
"Watching a product go from the initial clinical trial analysis to reality in a bottle is always very rewarding," said Travis Shoaf, Director of Manufacturing for Pharm Origins.
He added, "We have been on the lookout for the strongest possible cardiac active ingredient, and we have found it with Cholafarin."
The Cholafarin sublingual falls in line with the Pharm Origins core belief of delivering safe and naturally extracted active ingredients that rival pharmaceuticals at a fraction of the price.
Pharm Origins was founded in 2011 and is an FDA registered dietary supplement formulator and manufacturer located in Atlanta, GA.
SOURCE Pharm Origins
Share this article